Texas Instruments ( TXN) was downgraded at UBS to Neutral from Buy. $35 price target. Limited margin upside in near to mid term, UBS said. Worthington ( WOR) was upgraded at Goldman Sachs from Sell to Neutral. $18 price target. New engineered cabs business should boost earnings, Goldman said.
STOCK COMMENTS / EPS CHANGES
Charles River ( CRL) numbers were increased at Sterne Agee. Estimates were raised through 2013. Checks show that customer demand is becoming stronger, Sterne Agee said. CSX ( CSX) was added to US1 list at Bank of America/Merrill Lynch. Valuation call, based on a new $26 price target, BofA/Merrill said. CSX numbers were lowered at Jefferies. Shares are now seen reaching $28. Estimates were also lowered on mild weather, Jefferies said. Buy rating. Discover Financial ( DFS) numbers were boosted at Bank of America/Merrill Lynch. Estimates were also increased, as the company continues to operate in a sweet spot of the credit cycle. Buy rating. Dover Corp. ( DOV) numbers were raised at Credit Suisse. Shares are now seen reaching $69. Estimates were also raised on healthy book-to-bill and positive meetings with management, Credit Suisse said. Neutral rating. Finish Line ( FINL) numbers were reduced at Sterne Agee. Shares are now seen reaching $25. Estimates were also cut. Company is investing more on digital technologies, Sterne Agee said. Buy rating. Groupon ( GRPN) estimates, target cut at Benchmark. Shares are now seen reaching $28. Estimates were also reduced, given higher refund amounts, Benchmark said. Overweight rating. Pfizer ( PFE) price target was increased at Citigroup to $23. Divestitures are on track, but there is no plan to break up the pharma business, Citigroup said. Pier One ( PIR) numbers were raised at Keybanc. Shares are now seen reaching $21. Estimates were also increased, as a cyclical spending recovery should continue to unfold over the coming quarters, Keybanc said. Qualcomm ( QCOM) estimates and target were raised at Bank of America/Merrill Lynch. Shares are now seen reaching $75. Estimates also increased, as the company is leveraged to higher global handset growth, BofA/Merrill said. Buy rating. Starbucks ( SBUX) price target was raised to $70 at Williams Capital. Company is expanding with new products and locations, Williams said. Outperform rating. Schlumberger ( SLB) estimates and target were lowered at Dahlman Rose. Estimates were cut through 2013. Company is seeing lower North American pressure pumping results, Dahlman Rose said. Buy rating and new $89 price target.